Company insight
Vitamin K2: An essential ingredient for all stages of life
Clinical evidence confirms that vitamin K2 is an essential nutrient for supporting our health at every stage of life. As NattoPharma joins the Gnosis by Lesaffre family, everyone is able to benefit. The company now offers the most comprehensive portfolio of vitamin K2, fitting every brand owner’s needs and creating consumer-preferred delivery methods.
vitamin K2 players. The former is a pioneer in fermentation, offering unprecedented expertise. The latter has driven the research and development of vitamin K2 for the past 20 years, providing an understanding of K2 as MK-7, with more than 20 published human clinical trials confirming its safe and efficacious benefits for bone and cardiovascular health. This is ensured through the activation of osteocalcin and matrix GLA protein (MGP), respectively. These two trailblazers have joined forces to expand capabilities, global reach, and fuel future innovation as vitamin K2 demand grows, setting out on a big mission to spread the word about the power of vitamin K2. When it comes to shaping the future of the supplement industry, this essential nutrient deserves a spot alongside staple ingredients like omega-3s, folate, and vitamin B.
G An unparalleled offer
This newly combined product portfolio has something for every customer: ■ MenaQ7: Globally renowned as the first vitamin K2 ingredient on the market, MenaQ7 stands as the only clinically validated K2 ingredient in application. The subject of more than 20 clinical studies, MenaQ7 is a perfect premium option for brands with customers that demand clinically proven results.
■ VitaMK7: For brands where “all-natural” designation is paramount, vitaMK7 is a fantastic K2 option, naturally developed
44
nosis by Lesaffre and NattoPharma are two of the leading global
from complex combination products, liquids, dispersible formats, and gummies. By making K2 available in a broader range of finished product dose forms, appealing to young and older people, the combined solutions platform increases companies’ opportunities to deliver health benefits in various products designed for all ages.
The combined NattoPharma and Gnosis by Lesaffre portfolio enables finished product dose forms to appeal to, and benefit, both young and older people.
through a biotransformation process and available in a highly-concentrated form.
“Our combined K2 portfolio offers a complete level of choice that no other supplier can match,” says Philippe Caillat, global marketing director with Gnosis by Lesaffre. “If you are seeking the clinically validated, premium K2 option, we have MenaQ7 (which is available in several formats, including natural). If you seek to uphold all-natural label claims on your package, then vitaMK7 might be the right ingredient for your application. Our level of expertise in the K2 category is unsurpassed, and no matter the needs of your product, we have you covered.”
Enabling technologies
Ensuring stable menaquinone ingredients in any application is not a one-size-fits-all solution. The company offers the most optimal vitamin K2 solution to fit customer needs by developing and testing key solutions for various applications, ranging
The future of K2 Beyond proven bone and cardiovascular benefits, 2021 has shown an explosion of research linking the vitamin K2 mechanism – specifically its activation of MGP – to other potential health benefits including, but not limited to, joint, vision, brain and pulmonary health. “There’s a lot of exciting emerging research on vitamin K2, opening doors to potential application in pharmaceutical and functional food products with possible benefits ranging from immunity to infant health,” Caillat continues.
“This partnership is raising the bar for the global K2 market. With our combined resources, we will lead innovation for this exciting nutrient. “We are prepared to equip our customers with the tools they need – both science and support – to connect them with consumers so they can grow their businesses all while improving the state of global health.” This new union of pioneers provides the industry the most comprehensive K2 portfolio, backed by science and produced to the highest quality standards. ●
www.gnosisbylesaffre.com
www.nattopharma.com
Ingredients Insight /
www.ingredients-insight.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112
